NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.
NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.
Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.
FDA says new tools needed to speed therapeutics development.
Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.
CDC study finds obesity may become leading preventable cause of death; NIH research plan drafted.
Funding opportunities listed.
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- Preparing to take care of each other in ways we never imagined
